Garrett Wealth Advisory Group, LLC Abb Vie Inc. Transaction History
Garrett Wealth Advisory Group, LLC
- $487 Million
- Q3 2025
A detailed history of Garrett Wealth Advisory Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Garrett Wealth Advisory Group, LLC holds 4,011 shares of ABBV stock, worth $938,574. This represents 0.19% of its overall portfolio holdings.
Number of Shares
4,011
Previous 2,653
51.19%
Holding current value
$938,574
Previous $555,000
67.21%
% of portfolio
0.19%
Previous 0.12%
Shares
6 transactions
Others Institutions Holding ABBV
# of Institutions
4,489Shares Held
1.28BCall Options Held
17.1MPut Options Held
15.4M-
Vanguard Group Inc Valley Forge, PA178MShares$41.6 Billion0.64% of portfolio
-
Black Rock Inc. New York, NY136MShares$31.9 Billion0.54% of portfolio
-
State Street Corp Boston, MA79.8MShares$18.7 Billion0.66% of portfolio
-
Jpmorgan Chase & CO New York, NY56.5MShares$13.2 Billion0.86% of portfolio
-
Morgan Stanley New York, NY41.7MShares$9.75 Billion0.61% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $414B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...